Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...

Depolarizing Blockers: Mechanism of Action

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...

Depolarizing Blockers: Pharmocokinetics

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Ischemic stroke in childhood. A complication of tonsillectomy].

Revista espanola de anestesiologia y reanimacion·2015

Same author

[Giant cervical mass. An anesthetic challenge].

Revista espanola de anestesiologia y reanimacion·2014

Same author

[Repair of a laryngeal fissure in a patient with Opitz G/BBB syndrome].

Revista espanola de anestesiologia y reanimacion·2012

Same author

[Relationship between arginase activity and the storage time of packed red blood cells].

Revista espanola de anestesiologia y reanimacion·2012

Same author

[Reply to the article "Comments on the article Postdural puncture headache in obstetrics"].

Revista espanola de anestesiologia y reanimacion·2012

Same author

[Postdural puncture headache in obstetrics].

Revista espanola de anestesiologia y reanimacion·2012

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models

Published on: March 8, 2024

Extremely prolonged neuromuscular blockade after rocuronium: a case report.

A C Morales Martín¹, L M Vaquero Roncero, C Muriel Villoria

¹Departamento de Anestesia, Hospital Universitario de Salamanca, Paseo de San Vicente, Salamanca, Spain.

Acta Anaesthesiologica Scandinavica

|April 29, 2009

Summary

Rocuronium

Area of Science:

Anesthesiology and Pharmacology

Background:

Rocuronium neuromuscular blockade duration can vary significantly, especially in elderly patients.
Understanding these variations is crucial for safe anesthetic practice.

Observation:

A case of prolonged neuromuscular blockade from rocuronium, lasting 11 hours, was observed in a kidney transplant recipient.
This extended duration highlights potential patient-specific factors influencing drug metabolism and response.

Findings:

The prolonged effect of rocuronium suggests complex interactions between the drug and the patient's physiological state.
Potential contributing factors include renal function, drug interactions, and individual pharmacokinetics.

Implications:

This case underscores the need for vigilant monitoring of neuromuscular blockade duration in transplant patients.

More Related Videos

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy

Published on: June 25, 2013

Intra-Operative Neural Monitoring of Thyroid Surgery in a Porcine Model

Intra-Operative Neural Monitoring of Thyroid Surgery in a Porcine Model

Published on: February 11, 2019

Related Experiment Videos

Last Updated: Jun 23, 2026

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models

Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models

Published on: March 8, 2024

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy

Published on: June 25, 2013

Intra-Operative Neural Monitoring of Thyroid Surgery in a Porcine Model

Intra-Operative Neural Monitoring of Thyroid Surgery in a Porcine Model

Published on: February 11, 2019

Further research into factors affecting rocuronium pharmacodynamics in specific patient populations is warranted.